These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18149062)

  • 1. Studies on suramin; further observations on the combination of the drug with proteins.
    WILSON EJ; WORMALL A
    Biochem J; 1949; 45(2):224-31. PubMed ID: 18149062
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on suramin (antrypol: Bayer 205); the combination of the drug with the plasma and other proteins.
    DEWEY HM; WORMALL A
    Biochem J; 1946; 40(1):119-24. PubMed ID: 21027558
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of suramin in clinical samples using HPLC.
    Brandsteterová E; Chovancová V; Koza I; Mardiak J; Hal'ko J
    Neoplasma; 1991; 38(4):425-32. PubMed ID: 1922574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on suramin; the action of the drug on enzymes and some other proteins. General considerations.
    TOWN BW; WILLS ED; WILSON EJ; WORMALL A
    Biochem J; 1950 Aug; 47(2):149-58. PubMed ID: 14791337
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
    Zhang P; He JB; Ou LW; Wang XH
    Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
    Jennings FW
    Trop Med Parasitol; 1991 Sep; 42(3):157-60. PubMed ID: 1801135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of suramin on laboratory tests of coagulation.
    Horne MK; Wilson OJ; Cooper M; Gralnick HR; Myers CE
    Thromb Haemost; 1992 Apr; 67(4):434-9. PubMed ID: 1631791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer.
    Kelly WK; Scher HI; Mazumdar M; Pfister D; Curley T; Leibertz C; Cohen L; Vlamis V; Dnistrian A; Schwartz M
    J Clin Oncol; 1995 Sep; 13(9):2214-22. PubMed ID: 7666079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus.
    Lu JW; Hsieh PS; Lin CC; Hu MK; Huang SM; Wang YM; Liang CY; Gong Z; Ho YJ
    Biochem Biophys Res Commun; 2017 Sep; 491(3):595-602. PubMed ID: 28760340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines.
    Bellan C; Pic P; Marvaldi J; Fantini J; Pichon J
    Second Messengers Phosphoproteins; 1991; 13(4):163-71. PubMed ID: 1667418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits.
    Chung WC; Kermode JC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):191-8. PubMed ID: 15626724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
    Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
    Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
    Dua P; Ingle A; Gude RP
    Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis by suramin.
    Gagliardi A; Hadd H; Collins DC
    Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK studies on suramin therapy in hormone resistant prostate cancer.
    Kehinde EO; Terry TR; Mistry N; Horsburgh T; Sandhu DP; Bell PR
    Cancer Surv; 1995; 23():217-29. PubMed ID: 7621460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin inhibits cullin-RING E3 ubiquitin ligases.
    Wu K; Chong RA; Yu Q; Bai J; Spratt DE; Ching K; Lee C; Miao H; Tappin I; Hurwitz J; Zheng N; Shaw GS; Sun Y; Felsenfeld DP; Sanchez R; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2011-8. PubMed ID: 27001857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development.
    Chen D; Song SH; Wientjes MG; Yeh TK; Zhao L; Villalona-Calero M; Otterson GA; Jensen R; Grever M; Murgo AJ; Au JL
    Pharm Res; 2006 Jun; 23(6):1265-74. PubMed ID: 16715360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures.
    Michel P; Van Velthoven R; Petein M; Gras S; Etievant C; Pasteels JL; Kiss R
    Anticancer Res; 1991; 11(6):2075-8. PubMed ID: 1723262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay.
    Walther MM; Kragel PJ; Trahan E; Venzon D; Blair HC; Schlesinger PH; Jamai-Dow C; Ewing MW; Myers CE; Linehan WM
    Endocrinology; 1992 Nov; 131(5):2263-70. PubMed ID: 1425426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by suramin of protein synthesis in vitro. Ribosomes as the target of the drug.
    Brigotti M; Alfieri RR; Petronini PG; Carnicelli D
    Biochimie; 2006 May; 88(5):497-503. PubMed ID: 16386828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.